REG - Hutchison China Medi - Notice of Results

HUTCHMED (China)Announcement

26/06/2020 07:00

RNS Number : 9779Q
  
Hutchison China Meditech Limited
  
26 June 2020
  
 

Chi-Med to Announce 2020 Half-Year Financial Results
 
London: Friday, June 26, 2020: Hutchison China MediTech Limited ("Chi-Med") (Nasdaq/AIM: HCM) will be announcing its interim results for the six months ended June 30, 2020 on Thursday, July 30, 2020 at 12:00 noon British Summer Time (BST) (7:00 pm Hong Kong Time (HKT); 7:00 am Eastern Daylight Time (EDT)). 
 
Analysts and investors are invited to join a conference call and audio webcast presentation with Q&A, conducted by Chi-Med management.  
 
The conference call and audio webcast will take place at 1:00 pm BST / 8:00 pm HKT / 8:00 am EDT on Thursday, July 30, 2020 and will be webcast live via the company website at www.chi-med.com/investors/event-information/.  The presentation will be available for downloading before the conference call begins. Details of the conference call dial-in will be provided in the financial results announcement and on the company website.  A replay will also be available on the website shortly after the event.
 
 
About Chi-Med
 
Chi-Med (Nasdaq/AIM: HCM) is an innovative biopharmaceutical company committed, over the past twenty years, to the discovery and global development of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases.  It has a portfolio of eight cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. For more information, please visit: www.chi-med.com.
 
 
CONTACTS
 



Investor Enquiries








Mark Lee, Senior Vice President


+852 2121 8200




Annie Cheng, Vice President


+1 (973) 567 3786














Media Enquiries








Americas - Brad Miles, Solebury Trout


+1 (917) 570 7340 (Mobile) 
bmiles@troutgroup.com




Europe - Ben Atwell / Alex Shaw, FTI Consulting


+44 20 3727 1030 / +44 7771 913 902 (Mobile) / +44 7779 545 055 (Mobile)
Chi-Med@fticonsulting.com




Asia - Joseph Chi Lo / Zhou Yi, Brunswick


+852 9850 5033 (Mobile), jlo@brunswickgroup.com / +852 9783 6894 (Mobile), yzhou@brunswickgroup.com














Nominated Advisor








Freddy Crossley / Atholl Tweedie, Panmure Gordon (UK) Limited


+44 (20) 7886 2500



 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
NORDZGZVDDGGGZM